Kwality Pharmaceuticals
₹508.9
+16 (3.25%)
13 May, 2024 02:16 BSE: 539997
NSE: KPLISIN: INE552U01010
Start SIP in Kwality Pharmaceuticals
Start SIPKwality Pharmaceuticals Performance
Day Range
- Low 0
- High 0
52 Week Range
- Low 0
- High 0
- Open Price0
- Previous Close0
- Volume
Kwality Pharmaceuticals Financials
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 78 | 70 | 67 | 69 |
| Operating Expenses Qtr Cr | 61 | 54 | 54 | 57 |
| Operating Profit Qtr Cr | 17 | 15 | 14 | 12 |
| Depreciation Qtr Cr | 5 | 5 | 5 | 4 |
| Interest Qtr Cr | 3 | 2 | 2 | 2 |
| Tax Qtr Cr | 2 | 2 | 2 | -2 |
| Net Profit Qtr Cr | 8 | 6 | 5 | -7 |
Kwality Pharmaceuticals Technicals
EMA & SMA
Current Price
₹508.9
+16 (3.25%)
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹488.41
- 50 Day
- ₹474.74
- 100 Day
- ₹454.88
- 200 Day
- ₹424.59
- 20 Day
- ₹485.77
- 50 Day
- ₹473.26
- 100 Day
- ₹459.39
- 200 Day
- ₹411.36
Kwality Pharmaceuticals Resistance and Support
PIVOT
₹501.2
| Resistance | |
|---|---|
| First Resistance | 512.35 |
| Second Resistance | 520.05 |
| Third Resistance | 531.20 |
| RSI | 59.87 |
| MFI | 65.74 |
| MACD Single Line | 9.92 |
| MACD | 10.31 |
| Support | |
|---|---|
| First Resistance | 493.50 |
| Second Resistance | 482.35 |
| Third Resistance | 474.65 |
Kwality Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 7,492 | 661,094 | 88.24 |
| Week | 7,273 | 635,861 | 87.43 |
| 1 Month | 8,261 | 682,889 | 82.66 |
| 6 Month | 16,116 | 1,302,617 | 80.83 |
Kwality Pharmaceuticals Result Highlights
Kwality Pharmaceuticals Synopsis
NSE-Food-Packaged
M K Proteins belongs to the Industry of Edible Oils & Solvent Extraction. Company’s Total Operating Revenue is Rs. 314.86 Cr. and Equity Capital is Rs. 12.51 Cr. for the Year ended 31/03/2023. M K Proteins Ltd. is a Public Limited Listed company incorporated on 15/06/2012 and has its registered office in the State of Haryana, India. Company’s Corporate Identification Number(CIN) is L15500HR2012PLC046239 and registration number is 046239.| Market Cap | 415 |
| Sales | 474 |
| Shares in Float | 3.13 |
| No of funds | 1 |
| Yield |
| Book Value | 2.75 |
| U/D Vol ratio | 0.6 |
| LTDebt / Equity | 5 |
| Alpha | 0.1 |
| Beta | 0.23 |
Kwality Pharmaceuticals
| Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
|---|---|---|---|---|
| Promoters | 74.82% | 74.82% | 74.82% | 74.82% |
| Foreign Portfolio Investors | 0.02% | |||
| Individual Investors | 20.79% | 14.05% | 12.27% | 11.56% |
| Others | 4.37% | 11.13% | 12.91% | 13.62% |
Kwality Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Vinod Kumar | Executive Director |
| Mr. Raj Kumar | Non Exe.Non Ind.Director |
| Mr. Parvind Kumar | Non Executive Director |
| Mr. Parmod Kumar | Managing & Executive Director |
| Ms. Laxmi Mandal | Ind. Non-Executive Director |
| Mr. Tej Mohan Singh | Ind. Non-Executive Director |
| Mrs. Shipra Jain | Ind. Non-Executive Director |
| Mr. Swati Gupta | Ind. Non-Executive Director |
Kwality Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Kwality Pharmaceuticals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-05-23 | Audited Results | |
| 2024-02-06 | Quarterly Results | |
| 2023-11-04 | Quarterly Results | |
| 2023-08-10 | Quarterly Results | |
| 2023-05-27 | Audited Results |
Kwality Pharmaceuticals FAQs
What is Share Price of Kwality Pharmaceuticals ?
Kwality Pharmaceuticals share price is ₹508 As on 13 May, 2024 | 02:02
What is the Market Cap of Kwality Pharmaceuticals ?
The Market Cap of Kwality Pharmaceuticals is ₹528 Cr As on 13 May, 2024 | 02:02
What is the P/E ratio of Kwality Pharmaceuticals ?
The P/E ratio of Kwality Pharmaceuticals is 44.1 As on 13 May, 2024 | 02:02
What is the PB ratio of Kwality Pharmaceuticals ?
The PB ratio of Kwality Pharmaceuticals is 2.7 As on 13 May, 2024 | 02:02